Fengtao You
Overview
Explore the profile of Fengtao You including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
597
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
You F, Wang Y, Jiang L, Zhu X, Chen D, Yuan L, et al.
Am J Cancer Res
. 2019 Feb;
9(1):64-78.
PMID: 30755812
Chimeric antigen receptor (CAR) immunotherapy has recently shown promise in clinical trials for B-cell malignancies; however, designing CARs for T-cell based diseases remain a challenge since most target antigens are...
12.
Tang X, Yang L, Li Z, Nalin A, Dai H, Xu T, et al.
Am J Cancer Res
. 2018 Oct;
8(9):1899.
PMID: 30323981
[This corrects the article on p. 1083 in vol. 8, PMID: 30034945.].
13.
Tang X, Yang L, Li Z, Nalin A, Dai H, Xu T, et al.
Am J Cancer Res
. 2018 Jul;
8(6):1083-1089.
PMID: 30034945
CAR T cells have shown clinical efficacy for acute lymphoblastic leukemia, but this therapy has not been effective for acute myeloid leukemia (AML), and other treatment options are needed. Theoretically,...
14.
Chen Y, You F, Jiang L, Li J, Zhu X, Bao Y, et al.
Oncotarget
. 2017 Apr;
8(23):37128-37139.
PMID: 28415754
Natural killer (NK) cells play a pivotal role in monoclonal antibody-mediated immunotherapy through the antibody-dependent cell-mediated cytotoxicity (ADCC) mechanism. NK-92MI is an interleukin-2 (IL-2)-independent cell line, which was derived from...
15.
You F, Jiang L, Zhang B, Lu Q, Zhou Q, Liao X, et al.
Sci China Life Sci
. 2016 Mar;
59(4):386-97.
PMID: 26961900
Recent progress in chimeric antigen receptor-modified T-cell (CAR-T cell) technology in cancer therapy is extremely promising, especially in the treatment of patients with B-cell acute lymphoblastic leukemia. In contrast, due...
16.
You F, Ren W, Gu S, Wang W, Zhou L, Zhang Y, et al.
Gene
. 2012 May;
504(1):13-21.
PMID: 22588026
The finless porpoise (Neophocaena phocaenoides) is one of the smallest cetacean species. Research into the immune system of the finless porpoise is essential to the protection of this species, but,...
17.
You F, Zhou L, Liu X, Fan J, Ke Z, Ren W
Gene
. 2012 Mar;
498(2):196-202.
PMID: 22387304
A proliferation-inducing ligand (APRIL) is a novel member of the tumor necrosis factor (TNF) superfamily, which is involved in immune regulation. In the present study, the full-length cDNA of APRIL...
18.
You F, Ren W, Hou H, Pei L, He Z
Int Immunopharmacol
. 2012 Jan;
12(2):433-40.
PMID: 22236485
B cell activating factor (BAFF) belonging to the tumor necrosis factor (TNF) family is critical to B cell survival, proliferation, maturation, and immunoglobulin secretion and to T cell activation. In...
19.
Ren W, Pang S, You F, Zhou L, Zhang S
Fish Shellfish Immunol
. 2011 Oct;
31(6):1088-96.
PMID: 21959037
B-cell activating factor (BAFF), a member of the TNF family, is critical to the survival, proliferation, maturation, and differentiation of B-cells. In the present study, a CpBAFF was amplified from...
20.
Shen Y, You F, Li C, He Z, Liang Z, Ai H, et al.
Dev Comp Immunol
. 2011 Aug;
36(1):191-8.
PMID: 21801746
B-cell activating factor of the TNF family (BAFF) induces B cell survival, proliferation, immunoglobulin secretion and has a role in enhancing immune responses. In the present study, we amplified the...